Abstract
The cyclin-dependent kinases 4 and 6 (Cdk4/6) that drive progression through the G1 phase of the cell cycle play a central role in the control of cell proliferation, and CDK deregulation is a frequent event in cancer. Cdk4/6 are regulated by the D-type cyclins, which bind to CDKs and activate the kinase, and by the INK4 family of inhibitors. INK4 proteins can bind both monomeric CDK, preventing its association with a cyclin, and also the CDK-cyclin complex, forming an inactive ternary complex. In vivo, binary INK4–Cdk4/6 complexes are more abundant than ternary INK4–Cdk4/6–cyclinD complexes, and it has been suggested that INK4 binding may lead to the eventual dissociation of the cyclin. Here we present the 2.9-Å crystal structure of the inactive ternary complex between Cdk6, the INK4 inhibitor p18INK4c, and a D-type viral cyclin. The structure reveals that p18INK4c inhibits the CDK–cyclin complex by distorting the ATP binding site and misaligning catalytic residues. p18INK4c also distorts the cyclin-binding site, with the cyclin remaining bound at an interface that is substantially reduced in size. These observations support the model that INK4 binding weakens the cyclin's affinity for the CDK. This structure also provides insights into the specificity of the D-type cyclins for Cdk4/6.
References
40
Referenced
187
10.1182/blood.V90.1.126.126_126_137
/ Blood / Features of macrophage differentiation induced by p19INK4d, a specific inhibitor of cyclin D-dependent kinases. by Adachi (1997)10.1038/26164
10.1038/15674
10.1107/S0907444998003254
10.1093/emboj/19.12.2877
10.1107/S0907444994003112
10.1126/science.7997879
10.1002/j.1460-2075.1986.tb04288.x
/ EMBO J. / The relation between the divergence of sequence and structure in proteins. by Chothia (1986)10.1038/363595a0
10.1128/jvi.71.6.4193-4198.1997
/ J. Virol. / The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1. by Godden-Kent (1997)10.1091/mbc.7.1.57
10.1016/S0065-230X(08)60352-8
{'key': '2021111419251185000_14.24.3115.13', 'first-page': '1581', 'article-title': 'Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins.', 'volume': '11', 'author': 'Hall', 'year': '1995', 'journal-title': 'Oncogene'}
/ Oncogene / Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins. by Hall (1995)10.1128/MCB.15.5.2672
/ Mol. Cell. Biol. / Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. by Hirai (1995)10.1038/376313a0
10.1126/science.8153634
10.1038/sj.onc.1201036
10.1128/jvi.71.3.1984-1991.1997
/ J. Virol. / Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin. by Li (1997)10.1128/MCB.19.3.1981
/ Mol. Cell. Biol. / Induced expression of p16(INK4a) inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin–CDK-inhibitor complexes. by McConnell (1999){'key': '2021111419251185000_14.24.3115.20', 'first-page': '2077', 'article-title': 'Identification of G1 kinase activity for cdk6, a novel cyclin D partner.', 'volume': '14', 'author': 'Meyerson', 'year': '1994', 'journal-title': 'Mol. Cell. Biol.'}
/ Mol. Cell. Biol. / Identification of G1 kinase activity for cdk6, a novel cyclin D partner. by Meyerson (1994)10.1038/374131a0
10.1038/368753a0
10.1016/S0076-6879(97)76066-X
10.1002/j.1460-2075.1995.tb07026.x
/ EMBO J. / Lack of cyclin D–Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product. by Parry (1995)10.1006/jmbi.1999.2640
{'key': '2021111419251185000_14.24.3115.26', 'first-page': '305', 'article-title': 'The cell cycle kinases.', 'volume': '5', 'author': 'Pines', 'year': '1994', 'journal-title': 'Semin. Cancer Biol.'}
/ Semin. Cancer Biol. / The cell cycle kinases. by Pines (1994)10.1101/gad.11.4.492
10.1038/nsb0896-696
10.1038/26155
10.1016/S0969-2126(99)80035-5
/ Struct. Fold Des. / Crystal structure of a viral cyclin, a positive regulator of cyclin-dependent kinase 6. by Schulze-Gahmen (1999)10.1038/366704a0
10.1016/0092-8674(94)90540-1
10.1126/science.274.5293.1672
10.1101/gad.13.12.1501
10.1101/gad.10.12.1491
10.1038/36606
10.1016/S0969-2126(00)00036-8
10.1038/nsb0198-74
10.1126/science.7652577
10.1038/ng0196-97
Dates
Type | When |
---|---|
Created | 23 years ago (July 26, 2002, 8 p.m.) |
Deposited | 3 years, 9 months ago (Nov. 14, 2021, 10:40 p.m.) |
Indexed | 11 hours, 3 minutes ago (Aug. 21, 2025, 12:42 p.m.) |
Issued | 24 years, 8 months ago (Dec. 15, 2000) |
Published | 24 years, 8 months ago (Dec. 15, 2000) |
Published Online | 24 years, 8 months ago (Dec. 15, 2000) |
Published Print | 24 years, 8 months ago (Dec. 15, 2000) |
@article{Jeffrey_2000, title={Structural basis of inhibition of CDK–cyclin complexes by INK4 inhibitors}, volume={14}, ISSN={1549-5477}, url={http://dx.doi.org/10.1101/gad.851100}, DOI={10.1101/gad.851100}, number={24}, journal={Genes & Development}, publisher={Cold Spring Harbor Laboratory}, author={Jeffrey, Philip D. and Tong, Lily and Pavletich, Nikola P.}, year={2000}, month=dec, pages={3115–3125} }